As our previous study has proved that it is very common to screen single biomarker with low sensitivity [19], the merit of anti-UBQLN1 is that it not only can diagnose high-risk lung cancer patients from healthy individuals but also can be a promising biomarker in the discrimination of pulmonary nodules. This evidence concerns the gene UBQLN1 and lung carcinoma.